The world's second-largest healthcare provider by market value, IHH Healthcare, is tapping into the pulse of China and India's demographic trends through acquisitions and joint partnerships.
The Malaysia-based healthcare group, led by Dr. Tan See Leng, operates in over 10 countries with key markets in Singapore, Malaysia and Turkey, and has experienced healthy growth. Earnings before interest, taxes, depreciation and amortization (EBITDA) was up by 13 percent $347 million (1.5 billion Malaysian ringgit) in the first three quarters this year.
It is looking ahead by investing into the potential of economic heavyweights China and India, which will eventually "become [IHH Healthcare's] core markets."
Tan See Leng, managing director and CEO of IHH Healthcare, explains that the company's "objective is to use acquisitions as a main form of growing the company" and build around the acquired platform.
"We tend to acquire companies in markets that we're not familiar with, [therefore] we take on a more subdued role," explains Tan to CNBC's Managing Asia. "We don't start out with the objective of wanting to be number one."